(Q35150530)

6 August 2017

1 reference

title

34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective? (English)

1 reference

6 August 2017

1 reference

Paul Heidenreich

5

0 references

Daniel B. Mark

series ordinal

1

object named as

Daniel B Mark

1 reference

6 August 2017

2

Leslee J Shaw

1 reference

6 August 2017

3

Michael S Lauer

1 reference

6 August 2017

Patrick G O'Malley

4

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Journal of the American College of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

41

1 reference

6 August 2017

issue

11

1 reference

6 August 2017

page(s)

1906-1917

1 reference

Recent rapid increase in utilization of radionuclide myocardial perfusion imaging and related procedures: 1996-1998 practice patterns

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Coronary calcification by electron beam computed tomography and obstructive coronary artery disease: a model for costs and effectiveness of diagnosis as compared with conventional cardiac testing methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Evaluation of chest pain in patients with low to intermediate pretest probability of coronary artery disease by electron beam computed tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Economics of Noninvasive Diagnosis (END) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Factors affecting sensitivity and specificity of exercise electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Long-term effects of mammography screening: updated overview of the Swedish randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Is screening for breast cancer with mammography justifiable?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Mammographic screening: no reliable supporting evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cochrane review on screening for breast cancer with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Screening for lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Screening of infants and mortality due to neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Regression Models and Life-Tables (with discussion)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

The association between coronary calcification assessed by electron beam computed tomography and measures of extracoronary atherosclerosis: the Rotterdam Coronary Calcification Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Noninvasive prediction of coronary atherosclerosis by quantification of coronary artery calcification using electron beam computed tomography: Comparison with electrocardiographic and thallium exercise stress test results

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of populationwide educational approaches to reduce serum cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Coronary artery calcium: absolute quantification in nonenhanced and contrast-enhanced multi-detector row CT studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Variability of repeated coronary artery calcium measurements by electron beam tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Prevalence and clinical significance of accidental findings in electron-beam tomographic scans for coronary artery calcification

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Frequency and severity of "incidentalomas" encountered during electron beam computed tomography for coronary calcium in middle-aged army personnel.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Analysing public preferences for cancer screening programmes.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Use and misuse of the term "cost effective" in medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Economic foundations of cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 6. Cost effectiveness of assessment and management of risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Costeffectiveness of diagnostic tests

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Is carotid intima-media thickness useful in cardiovascular disease risk assessment? The Rotterdam Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Coronary calcium does not accurately predict near-term future coronary events in high-risk adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Importance of perspective in economic analyses of cancer screening decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of a single colonoscopy in screening for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Yield of mammography in selected patients age < or = 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Task force #2--the cost of prevention: can we afford it? Can we afford not to do it? 33rd Bethesda Conference

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

The costs of prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of interventions to prevent or treat coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of screening for asymptomatic carotid atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cervical cancer screening: American College of Preventive Medicine practice policy statement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Prediction of Coronary Heart Disease Using Risk Factor Categories

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Coronary Artery Calcification in Older Adults to Age 99

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost comparison of electron beam tomography with conventional computed tomography scanning

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Predicting Quality of Well-being scores from the SF-36: results from the Beaver Dam Health Outcomes Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Computed tomography and magnetic resonance imaging for noninvasive coronary angiography and plaque imaging: current and potential future concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Introduction: mass screening, health technology assessment, and health policy in some European countries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Cost-effectiveness of diagnostic strategies for patients with chest pain

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Noninvasive imaging for the diagnosis of coronary artery disease: focusing the development of new diagnostic technology

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

Diagnosis of suspected coronary artery disease in women: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900362-0

7 January 2021

10.1016/S0735-1097(03)00362-0

Identifiers

DOI

1 reference

6 August 2017

1 reference